Mini reviews in medicinal chemistry

Psilocybin’s medical potential based on clinical trials and its impact on drug scheduling

Updated

Abstract

Psilocybin shows potential as a treatment for various psychiatric conditions, including treatment-resistant depression and post-traumatic stress disorder.

  • A growing body of evidence suggests effectiveness in treating psychiatric conditions such as generalized anxiety disorder and substance use disorders.
  • Psilocybin acts as a serotonin 2A receptor agonist, influencing brain networks related to emotional regulation and cognitive flexibility.
  • Controlled trials indicate that psilocybin, used alongside structured psychotherapy, can lead to lasting improvements in mood and emotional well-being.
  • Mild and self-limiting side effects, such as nausea and headaches, suggest a favorable safety profile.
  • Further research is needed to optimize dosing and assess long-term safety and effectiveness.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free